EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas

BACKGROUND: Squamous cell carcinomas (SCC) account for approximately 30% of non-small cell lung cancer (NSCLC). Current staging methods do not adequately predict outcome for this disease. EMX2 is a homeo-domain containing transcription factor known to regulate a key developmental pathway. This study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Yue, Dongsheng, Li, Hui, Che, Juanjuan, Zhang, Yi, Tolani, Bhairavi, Mo, Minli, Zhang, Hua, Zheng, Qingfeng, Yang, Yue, Cheng, Runfen, Jin, Joy Q., Luh, Thomas W., Yang, Cathryn, Tseng, Hsin-Hui K., Giroux-Leprieur, Etienne, Woodard, Gavitt A., Hao, Xishan, Wang, Changli, Jablons, David M., He, Biao
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4488446/
https://ncbi.nlm.nih.gov/pubmed/26132438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0132134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados